Moreover, the standard treatments for aggressive breast cancer are still limited due to a lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 (HER-2) expressions [5]. The gene discussed is ERBB2; the disease is breast carcinoma.